- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 305964, 8 pages
Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia
1Department of Biomedicine, University Women’s Hospital, 4031 Basel, Switzerland
2Biozentrum, University of Basel, 4056 Basel, Switzerland
3Laboratory for Prenatal Medicine, Department of Biomedicine, University Women’s Hospital, Hebelstrasse 20, CH 4031 Basel, Switzerland
Received 31 May 2011; Revised 26 December 2011; Accepted 28 December 2011
Academic Editor: Saulius Butenas
Copyright © 2012 Varaprasad Kolla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
List of proteins whose abundance in maternal plasma differed between cases and controls.
This table lists 63 proteins for which quantitative differences could be determined by iTRAQ mass spectrometric analysis between cases which developed preeclampsia (PE) or which had normal deliveries (Nor).
The blue columns indicate the normalized values for the control cases, while the orange column indicates the normalized values for cases which developed PE.
The table also includes the log transformed values, as well as the % variation form the mean. The graph indicates the distribution of the normalized values (red is PE and blue is Nor).